Range Res (RRC) Holding Has Increased by Quaker Capital Investments Llc; As Abbvie (ABBV) Market Valuation Declined, Atlantic Trust Group Has Decreased Position

Range Resources Corporation (NYSE:RRC) Logo

Quaker Capital Investments Llc increased its stake in Range Res Corp (RRC) by 595.26% based on its latest 2018Q2 regulatory filing with the SEC. Quaker Capital Investments Llc bought 1.49 million shares as the company’s stock declined 7.10% while stock markets rallied. The institutional investor held 1.74 million shares of the oil & gas production company at the end of 2018Q2, valued at $29.16 million, up from 250,700 at the end of the previous reported quarter. Quaker Capital Investments Llc who had been investing in Range Res Corp for a number of months, seems to be bullish on the $3.63 billion market cap company. The stock decreased 1.07% or $0.16 during the last trading session, reaching $14.83. About 8.00 million shares traded or 15.74% up from the average. Range Resources Corporation (NYSE:RRC) has declined 13.84% since November 29, 2017 and is downtrending. It has underperformed by 29.46% the S&P500. Some Historical RRC News: 24/04/2018 – OilVoice: [Press] Range Resources: Quarterly Activities Report; 25/04/2018 – Range Resources 1Q Rev $742.6M; 25/04/2018 – RANGE RESOURCES CORP – PRODUCTION FOR FULL YEAR 2018 IS EXPECTED TO AVERAGE APPROXIMATELY 2.2 BCFE PER DAY; 25/04/2018 – Range Resources 1Q Net $49.2M; 06/04/2018 – RRC of Texas: RRC Accepting Comments on Rule Amendments for Pipeline Fees; 16/04/2018 – Range Announces Credit Facility Renewal and Extension; 24/05/2018 – Range Resources Rises on Production Milestone; Plus500 Plans to Move to London Main Market; 16/04/2018 – RANGE – CREDIT AGREEMENT IS A REVOLVING CREDIT FACILITY OF $4 BLN, A BORROWING BASE OF $3.0 BLN, TOTAL LENDER COMMITMENTS OF $2.0 BLN; 23/03/2018 – ProactiveInvstrs: Range Resources: Broker repeats `buy’ recommendation with 200% upside; 29/05/2018 – Range Resources Starts Operations at Indonesia Project

Atlantic Trust Group Llc decreased its stake in Abbvie Inc (ABBV) by 12.88% based on its latest 2018Q2 regulatory filing with the SEC. Atlantic Trust Group Llc sold 94,422 shares as the company’s stock declined 4.45% while stock markets rallied. The institutional investor held 638,545 shares of the major pharmaceuticals company at the end of 2018Q2, valued at $59.16M, down from 732,967 at the end of the previous reported quarter. Atlantic Trust Group Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $135.24B market cap company. The stock increased 1.09% or $0.97 during the last trading session, reaching $89.91. About 3.83 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 6.26% since November 29, 2017 and is uptrending. It has underperformed by 9.36% the S&P500. Some Historical ABBV News: 10/04/2018 – Samsung Bioepis may pay 5% of Humira biosimilar sales as royalty to AbbVie, insiders say; 30/05/2018 – GILEAD SCIENCES INC – CHINA DRUG ADMINISTRATION APPROVES EPCLUSA(SOFOSBUVIR/VELPATASVIR), GILEAD’S PAN-GENOTYPIC TREATMENT FOR CHRONIC HEPATITIS C VIRUS INFECTION; 01/05/2018 – ABBVIE SUBMITS MARKETING AUTHORIZATION APPLICATION TO EMA FOR; 24/04/2018 – AstraZeneca: Imfinzi Monotherapy Wasn’t Powered for Statistical Significance; 10/04/2018 – Oncolytics Biotech: Combination Therapy With REOLYSIN(R), Keytruda(R) and/or anti-CD73 Immunotherapy Led to Rejection of Pre-Established Tumors; 16/04/2018 – Shire sells cancer drugs to Servier for $2.4 bln as Takeda circles; 29/05/2018 – AbbVie at Goldman Sachs Global Health Care Conference Jun 12; 10/04/2018 – AbbVie: Regulatory Submissions for Elagolix in Uterine Fibroids Remain on Track; 26/04/2018 – MOODY’S: ABBVIE’S SHR REPURCHASE ACCELERATION CREDIT NEGATIVE; 17/04/2018 – CYCLACEL’S CYC065 CDK INHIBITOR SHOWS SYNERGY WITH VENETOCLAX

Among 25 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 12 Hold. Therefore 40% are positive. Abbvie Inc had 103 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, March 26 by Bank of America. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Goldman Sachs on Friday, March 10. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Monday, June 26. The rating was maintained by Credit Suisse on Monday, January 29 with “Hold”. On Friday, April 13 the stock rating was maintained by Jefferies with “Buy”. Jefferies maintained it with “Buy” rating and $94 target in Monday, July 17 report. The stock of AbbVie Inc. (NYSE:ABBV) has “Underperform” rating given on Tuesday, January 30 by BMO Capital Markets. UBS maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, October 13. UBS has “Neutral” rating and $9 target. The rating was initiated by SunTrust on Wednesday, July 22 with “Buy”. The firm earned “Outperform” rating on Friday, September 2 by Raymond James.

Investors sentiment increased to 0.94 in 2018 Q2. Its up 0.24, from 0.7 in 2018Q1. It improved, as 55 investors sold ABBV shares while 614 reduced holdings. 107 funds opened positions while 524 raised stakes. 1.00 billion shares or 5.08% less from 1.06 billion shares in 2018Q1 were reported. Keybank Association Oh reported 0.7% in AbbVie Inc. (NYSE:ABBV). Holderness Investments Company holds 13,923 shares. Jpmorgan Chase & has invested 0.14% in AbbVie Inc. (NYSE:ABBV). Beacon Grp reported 8,651 shares or 0.14% of all its holdings. Everett Harris And Ca invested in 0.95% or 377,295 shares. Secor Capital LP reported 30,404 shares stake. Fiera has invested 0.11% in AbbVie Inc. (NYSE:ABBV). Utd Fire Gru Inc reported 3,408 shares. Thompson Mgmt owns 64,138 shares for 1.08% of their portfolio. 159,482 are held by Gamble Jones Inv Counsel. 85,968 were reported by Old Mutual Customised Solutions (Proprietary) Ltd. 1,000 are owned by Sarissa Cap Management L P. Meeder Asset Mngmt, Ohio-based fund reported 68,299 shares. Notis reported 1.81% of its portfolio in AbbVie Inc. (NYSE:ABBV). Mark Sheptoff Planning Lc owns 43,072 shares.

Atlantic Trust Group Llc, which manages about $24.52 billion US Long portfolio, upped its stake in Pra Health Sciences Inc by 6,065 shares to 176,036 shares, valued at $16.43M in 2018Q2, according to the filing. It also increased its holding in Abbott Labs (NYSE:ABT) by 145,756 shares in the quarter, for a total of 2.12M shares, and has risen its stake in Biogen Inc (NASDAQ:BIIB).

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Prnewswire.com which released: “Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie’s Humira Sales Practices – PRNewswire” on November 09, 2018, also Seekingalpha.com with their article: “AbbVie Delivers A Solid Beat And Raise Quarter – Seeking Alpha” published on November 08, 2018, Seekingalpha.com published: “AbbVie’s elagolix successful in late-stage uterine fibroid studies – Seeking Alpha” on November 15, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “December 2018 Stock Considerations – Seeking Alpha” published on November 28, 2018 as well as Fool.com‘s news article titled: “Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC – Motley Fool” with publication date: November 13, 2018.

Since June 15, 2018, it had 2 buys, and 2 insider sales for $6.03 million activity. 5,400 AbbVie Inc. (NYSE:ABBV) shares with value of $496,274 were bought by TILTON GLENN F. SEVERINO MICHAEL sold $4.88 million worth of AbbVie Inc. (NYSE:ABBV) on Friday, August 17. 17,588 shares were sold by RICHMOND TIMOTHY J., worth $1.75 million on Friday, June 15.

Among 46 analysts covering Range Resources Corp. (NYSE:RRC), 24 have Buy rating, 3 Sell and 19 Hold. Therefore 52% are positive. Range Resources Corp. had 160 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Range Resources Corporation (NYSE:RRC) has “Buy” rating given on Wednesday, September 28 by GMP Securities. Credit Suisse maintained Range Resources Corporation (NYSE:RRC) rating on Thursday, January 25. Credit Suisse has “Outperform” rating and $23 target. On Monday, February 6 the stock rating was upgraded by Instinet to “Buy”. The stock of Range Resources Corporation (NYSE:RRC) earned “Hold” rating by KeyBanc Capital Markets on Tuesday, September 5. Cowen & Co maintained it with “Buy” rating and $30.0 target in Wednesday, September 27 report. Raymond James downgraded the shares of RRC in report on Tuesday, March 22 to “Market Perform” rating. RBC Capital Markets maintained the shares of RRC in report on Thursday, March 1 with “Buy” rating. The firm has “Buy” rating by Susquehanna given on Thursday, January 25. The rating was initiated by Drexel Hamilton on Thursday, February 18 with “Buy”. The firm has “Hold” rating given on Monday, October 23 by J.P. Morgan.

Since June 1, 2018, it had 1 buy, and 2 insider sales for $213,737 activity. Ginn Dori sold $23,489 worth of Range Resources Corporation (NYSE:RRC) on Friday, June 1. VENTURA JEFFREY L sold $153,773 worth of Range Resources Corporation (NYSE:RRC) on Monday, July 9. SailingStone Capital Partners LLC also bought $7,197 worth of Range Resources Corporation (NYSE:RRC) shares.

Range Resources Corporation (NYSE:RRC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.